REFLUDAN Safety Questions, REFLUDAN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about REFLUDAN. Our extensive database of REFLUDAN adverse events and REFLUDAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about REFLUDAN
REFLUDAN Safety Reports
Total REFLUDAN reports: 5.REFLUDAN FDA safety alerts: No.
Reported hospitalizations: 1.
Take REFLUDAN Side Effects Survey or Share Your REFLUDAN Story. REFLUDAN Usage.
Physician from FRANCE reported REFLUDAN problem on Feb 15, 2007. Female patient, 64 years of age, was treated with REFLUDAN. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, platelet count decreased. REFLUDAN dosage: unknown. Patient recovered.
REFLUDAN problem was reported by a Consumer or non-health professional from FRANCE on Mar 21, 2007. Female patient, 76 years of age, was diagnosed with hypertension, anaemia, pancreatic insufficiency, menopause and was treated with REFLUDAN. After drug was administered, patient experienced the following problems/side effects: muscle spasms, tetany. REFLUDAN dosage: 2 MG FOR 4 HOURS, 3X/WEEK. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, MOLSIDOMINE, ISOSORBIDE MONONITRATE, ENALAPRIL MALEATE, EPOGEN, FERRIGLUCONATE, PANCREATIN TRIPLE STRENGTH CAP, OESTRIOL. Patient recovered.
Physician from UNITED STATES reported REFLUDAN problem on Apr 11, 2006. Male patient, 72 years of age, was treated with REFLUDAN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. REFLUDAN dosage: unknown. Patient recovered.
REFLUDAN problem was reported by a Health Professional from UNITED STATES on Oct 16, 2006. Male patient, 73 years of age, weighting 172.0 lb, was diagnosed with heparin-induced thrombocytopenia, atrial fibrillation and was treated with REFLUDAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac tamponade, heparin-induced thrombocytopenia, pericardial effusion, pleural effusion, post procedural haemorrhage, surgical procedure repeated, ventricular tachycardia. REFLUDAN dosage: unknown. During the same period patient was treated with ANGIOMAX, HEPARIN, ASPIRIN, COUMADIN, AMIODARONE. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported REFLUDAN problem on Sept 10, 2007. Male patient, 75 years of age, was treated with REFLUDAN. After drug was administered, patient experienced the following problems/side effects: thrombosis in device. REFLUDAN dosage: unknown. Patient recovered.